FinVector Oy
Riikka Kalliokoski is a QC Specialist at FinVector Oy since November 2021, managing Long Term Stability studies in Quality Control and preparing batch release documentation. Previously, Kalliokoski served as Laboratory Manager at TILT Biotherapeutics Ltd from January 2017 to October 2021, overseeing laboratory management tasks including protocols and study plans. Experience also includes working as a Technical Assistant Biology at Lead Discovery Center GmbH, where responsibilities encompassed pre-clinical drug discovery and various laboratory techniques. Kalliokoski's earlier roles include a Research Assistant position at the National Institute for Health and Welfare and a Production Worker role at Reagena Oy Ltd. Kalliokoski holds a Master of Health Care in Biomedical Laboratory Science from Savonia University of Applied Sciences, and a Bachelor of Social and Health Care from the same institution, as well as education from the University of Eastern Finland.
This person is not in the org chart
This person is not in any teams
FinVector Oy
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for theproduction of gene therapy products for clinical and commercial supply.